Apex Healthcare Bhd (XKLS:7090) Research & Development: RM0.0 Mil (TTM As of Sep. 2025)


XKLS:7090 Apex Healthcare Bhd XKLS:7090
63 GF Score
Price RM2.61
GF Value RM2.27
! 7 Warning Signs
View Full Analysis

What is Apex Healthcare Bhd Research & Development?

Apex Healthcare Bhd XKLS:7090 63 Research & Development is RM0.0 Mil as of Sep. 2025. GuruFocus rates XKLS:7090 with a GF Score™ of 63/100 and a GF Value™ of RM2.27. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Apex Healthcare Bhd's Research & Development for the three months ended in Sep. 2025 was RM0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was RM0.0 Mil.

Apex Healthcare Bhd  (XKLS:7090) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Apex Healthcare Bhd Research & Development Related Terms

Apex Healthcare Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Apex Healthcare Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apex Healthcare Bhd Research & Development Chart

Apex Healthcare Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Apex Healthcare Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:7090
63GF Score
Apex Healthcare Bhd XKLS:7090
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apex Healthcare Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.0 Mil mean?
Apex Healthcare Bhd (XKLS:7090) has a Research & Development of RM0.0 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Apex Healthcare Bhd and its competitors.
Is Apex Healthcare Bhd's Research & Development too high?
Apex Healthcare Bhd's current Research & Development is RM0.0 Mil. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Research & Development compare to MCK and COR?
Apex Healthcare Bhd's Research & Development of RM0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Apex Healthcare Bhd and its competitors. Apex Healthcare Bhd's current Research & Development is RM0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Research & Development of RM0.0 Mil. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Research & Development is RM0.0 Mil. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Research & Development is RM0.0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued. The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.

Key valuation signals for XKLS:7090:

  • Research & Development: RM0.0 Mil
  • GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apex Healthcare Bhd Business Description

Address 1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score

Get the complete analysis for XKLS:7090

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.61
Price
RM2.27
GF Value